Although the current report is limited by the small sample size, our observations suggest that positive EGFR expression is relatively well-preserved during the metastatic progression from primary NSCLC to lymph node metastases. The gene discussed is EGFR; the disease is metastatic malignant neoplasm in the lymph nodes.